Glenview Trust CO Boston Scientific Corp Transaction History

Glenview Trust CO

$4.84 Billion
Q2 2024

A detailed history of Glenview Trust CO transactions in Boston Scientific Corp stock. As of the latest transaction made, Glenview Trust CO holds 31,192 shares of BSX stock, worth $2.61 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

31,192

Previous 29,651 5.2%

Holding current value

$2.61 Million

Previous $2.03 Million 18.33%

% of portfolio

0.05%

Previous 0.04%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$67.33 - $77.71 $103,755 - $119,751	1,541 Added 5.2%	31,192 $2.4 Million
Q1 2024 May 14, 2024	BUY	$57.6 - $68.62 $2,188 - $2,607	38 Added 0.13%	29,651 $2.03 Million
Q4 2023 Feb 12, 2024	BUY	$48.64 - $57.81 $6,177 - $7,341	127 Added 0.43%	29,613 $1.71 Million
Q3 2023 Nov 13, 2023	BUY	$50.19 - $54.68 $2,710 - $2,952	54 Added 0.18%	29,486 $1.56 Million
Q2 2023 Aug 14, 2023	SELL	$49.72 - $54.64 $71,497 - $78,572	-1,438 Reduced 4.66%	29,432 $1.59 Million
Q1 2023 May 09, 2023	BUY	$45.09 - $50.03 $1,758 - $1,951	39 Added 0.13%	30,870 $1.54 Million
Q4 2022 Feb 08, 2023	BUY	$39.56 - $47.22 $395,085 - $471,586	9,987 Added 47.91%	30,831 $1.43 Million
Q3 2022 Nov 04, 2022	BUY	$36.71 - $109.66 $288,026 - $860,392	7,846 Added 60.36%	20,844 $807,000
Q2 2022 Aug 10, 2022	BUY	$35.24 - $47.1 $2,290 - $3,061	65 Added 0.5%	12,998 $484,000
Q1 2022 May 11, 2022	BUY	$40.9 - $45.1 $528,959 - $583,278	12,933 New	12,933 $573,000
Q4 2021 Feb 10, 2022	SELL	$38.07 - $44.87 $178,167 - $209,991	-4,680 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$38.58 - $44.24 $180,554 - $207,043	4,680 New	4,680 $200,000

Others Institutions Holding BSX

# of Institutions

1,449

Shares Held

1.21B

Call Options Held

8.14M

Put Options Held

8.3M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $120B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenview Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Glenview Trust CO with notifications on news.

Account

Glenview Trust CO Boston Scientific Corp Transaction History